Waverley Pharma Inc V.WAVE

Healthcare Biotechnology

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.

TSXV:WAVE - Post by User

Waverley Pharma Inc > I am out WAVE for now

<< Previous

Bullboard Posts

Next >>

Comment by flight100on Sep 08, 2020 5:54pm

139 Views

Post# 31524288

RE:I am out WAVE for now

Given that WAVE price closed at 0.175, think my decision of selling WAVE between 0.22-0.245 seemed to be a good decision!

Problem is that we as retail investor don't know how many shares the insiders or their associates plan to sell. WAVE has a lot of potential, however, the stock needs a lot of volume at higher price to sustain better pricing.

<< Previous

Bullboard Posts

Next >>

BlackBerry partners with Avathon to enhance critical event management with AI